Repligen Corp
RGEN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| !#& | LOCK|yCCG | LOCK|d?Qj^%^ |
Repligen Earnings: Strong Growth and Margin Expansion Despite Filtration and Inflation Headwinds
Repligen reported 12.5% year-on-year organic revenue growth and adjusted EBITDA margin expansion of 1.9 percentage points. Management now expects full-year adjusted EBITDA margin of 21%, at the top of its previous guidance range of 20.6%-21.0%.
